CURE’s leukemia page is a go-to resource for oncology news and updates in the world of leukemia Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in leukemia.
April 23rd 2024
The investigational drug ziftomenib is currently being evaluated for patients with relapsed/refractory NPM1-mutant acute myeloid leukemia.
FDA Approval of Jakafi for Chronic GVHD Provides Another Option, But ‘More Work Needs to Be Done’
September 29th 2021While the recent FDA approval of Jakafi offers another effective option for patients with chronic GVHD, one expert urges that more work needs to be done to prevent and/or reverse the condition.
Chronic GVHD Treatment Improves, But Is Still Far From Perfect
September 20th 2021Patients with blood cancer who underwent stem cell transplant and developed chronic graft-versus-host disease have more treatment options than ever before. But the formula for planning older and newer therapies has not yet been established.